Using biomarkers to define disease risk in pre-clinical Alzheimer’s disease
2019.4.3
Lefkos Middleton Imperial College London, UK
14:00h
Auditorium iCBR/IBILI, FMUC-polo 3
Host: João Malva and Ana Cristina Rego
Back
 
   
Funded by ERDF - European Regional Development Fund through COMPETE 2020 and National Funds via FCT - Fundação para a Ciência e Tecnologia, under projects POCI-01-0145-FEDER-007440 e UIDB/04539/2020.

© 2020 CNC - Center for Neuroscience and Cell Biology
powered by DigitalWind